{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:42:42Z","timestamp":1794850962387,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Several trend analyses on liver transplantation (LT) indications have been published in the U.S. and in other countries, but there are limited data on LT indication trends in Saudi Arabia (SA), especially since the availability of direct-acting antivirals (DAAs) treatment for hepatitis C virus (HCV). This study aimed to analyze trends in the frequency of LT indications among LT recipients in SA over a 19-year period and examine associations between etiologic-specific trends and clinicodemographic characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study analyzed clinical and surgical data of adult patients (n\u2009=\u20091009) who underwent LT at the King Faisal Specialist Hospital &amp; Research Center (Riyadh, SA) between 2001 and 2019. Spearman\u2019s rank correlation, Poisson regression, and Joinpoint regression analysis were employed to assess changes in LT etiologic trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the first period (2001\u20132010), the main LT indications were HCV (41.9%) and hepatitis B virus (HBV) (21.1%), but nonalcoholic steatohepatitis (NASH) (29.7%) surpassed HCV (23.7%) as the leading LT indication in the second period (2011\u20132019); and the trends were significant in correlation analyses [incidence rate ratio (IRR)\u2009=\u20091.09 (1.06\u20131.13) for NASH; IRR\u2009=\u20090.93 (0.91\u20130.95) for HCV]. In the Joinpoint regression analysis, increases in NASH from 2006 to 2012 (+\u00a032.1%) were statistically significant, as were the decreases in HCV from 2004 to 2007 (\u2212\u200919.6%) and from 2010 to 2019 (\u2212\u200912.1%). Similar patterns were observed in LT etiological comparisons before and after the availability of DAAs and within hepatocellular carcinoma stratifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Trends in the epidemiology of LT indications among LT recipients in SA have changed over a 19-year period. Most notably, NASH has eclipsed HCV in the country due to the effective treatment strategies for HCV. These trends in NASH now need an aggressive public health response to minimize and avert future onset of additional clinical and economic strains on health care systems and LT centers in SA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-021-01828-z","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:34:29Z","timestamp":1622547269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Saleh A.","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter C.","family":"Broering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid I.","family":"Bzeizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noara","family":"Alhusseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh I.","family":"Alabbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Albenmousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreen","family":"Alfaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Abaalkhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed K.","family":"Al-hamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"1","key":"1828_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151\u201371.","journal-title":"J Hepatol"},{"issue":"6","key":"1828_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00595-020-01996-7","volume":"50","author":"S Dolnikov","year":"2020","unstructured":"Dolnikov S, Adam R, Cherqui D, Allard MA. Liver transplantation in elderly patients: what do we know at the beginning of 2020? Surg Today. 2020;50(6):533\u20139.","journal-title":"Surg Today"},{"issue":"3","key":"1828_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","volume":"19","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol. 2021;19(3):580-589.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"1828_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21037\/amj.2018.03.12","volume":"3","author":"N Faisal","year":"2018","unstructured":"Faisal N. Hepatitis C and liver transplantation in direct acting antiviral era. AME Med J. 2018;3(3):40\u20135.","journal-title":"AME Med J"},{"issue":"4","key":"1828_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jhep.2018.06.010","volume":"69","author":"LS Belli","year":"2018","unstructured":"Belli LS, Perricone G, Adam R, Cortesi PA, Strazzabosco M, Facchetti R, et al. Impact of DAAs on liver transplantation: major effects on the evolution of indications and results. An ELITA study based on the ELTR registry. J Hepatol. 2018;69(4):810\u20137.","journal-title":"J Hepatol."},{"issue":"12","key":"1828_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/tri.13358","volume":"31","author":"R Adam","year":"2018","unstructured":"Adam R, Karam V, Cailliez V, O Grady JG, Mirza D, Cherqui D, et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR) 50-year evolution of liver transplantation. Transplant Int. 2018;31(12):1293\u2013317.","journal-title":"Transplant Int."},{"key":"1828_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/DMSO.S146339","volume":"11","author":"R Sarwar","year":"2018","unstructured":"Sarwar R, Pierce N, Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes Metab Syndr Obes Targets Ther. 2018;11:533\u201342.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"1","key":"1828_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000282080","volume":"28","author":"S Bellentani","year":"2010","unstructured":"Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155\u201361.","journal-title":"Dig Dis"},{"issue":"10113","key":"1828_CR9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"(NCD-RisC) NRFC","year":"2017","unstructured":"(NCD-RisC) NRFC. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390(10113):2627\u201342.","journal-title":"Lancet."},{"issue":"3","key":"1828_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.7150\/ijbs.29599","volume":"15","author":"R Divella","year":"2019","unstructured":"Divella R, Mazzocca A, Daniele A, Sabb\u00e0 C, Paradiso A. Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer. Int J Biol Sci. 2019;15(3):610\u20136.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"1828_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u201364.","journal-title":"Gastroenterology"},{"issue":"4","key":"1828_CR12","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457\u201369.","journal-title":"Hepatology"},{"key":"1828_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01709-7","author":"P Kasper","year":"2020","unstructured":"Kasper P, Martin A, Lang S, K\u00fctting F, Goeser T, Demir M, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2020. https:\/\/doi.org\/10.1007\/s00392-020-01709-7.","journal-title":"Clin Res Cardiol"},{"key":"1828_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1471-230X-14-65","volume":"14","author":"A Josefsson","year":"2014","unstructured":"Josefsson A, Fu M, Bj\u00f6rnsson E, Kalaitzakis E. Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis. BMC Gastroenterol. 2014;14:65.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"1828_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"issue":"5","key":"1828_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","volume":"126","author":"J Cai","year":"2020","unstructured":"Cai J, Zhang XJ, Ji YX, Zhang P, She ZG, Li H. Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases. Circ Res. 2020;126(5):679\u2013704.","journal-title":"Circ Res"},{"issue":"16","key":"1828_CR17","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.3390\/ijms21165888","volume":"21","author":"A Lonardo","year":"2020","unstructured":"Lonardo A, Leoni S, Alswat KA, Fouad Y. History of nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(16):5888.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1828_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/diagnostics11010098","volume":"11","author":"S Ballestri","year":"2021","unstructured":"Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F, et al. Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease. Diagnostics. 2021;11(1):98.","journal-title":"Diagnostics"},{"issue":"5","key":"1828_CR19","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1053\/j.gastro.2020.07.050","volume":"159","author":"M Noureddin","year":"2020","unstructured":"Noureddin M, Jones C, Alkhouri N, Gomez EV, Dieterich DT, Rinella ME, et al. Screening for nonalcoholic fatty liver disease in persons with type 2 diabetes in the united states is cost-effective: a comprehensive cost-utility analysis. Gastroenterology. 2020;159(5):1985-1987.e4.","journal-title":"Gastroenterology"},{"key":"1828_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12876-015-0407-y","volume":"15","author":"M Stepanova","year":"2015","unstructured":"Stepanova M, Henry L, Garg R, Kalwaney S, Saab S, Younossi Z. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis. BMC Gastroenterol. 2015;15:175.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1828_CR21","first-page":"766","volume":"54","author":"M Jawdat","year":"1992","unstructured":"Jawdat M, Qattan N, Al Karawi M, Mohamed AE, Khalil H. The first liver transplant in Saudi Arabia and the Arab world. Transplant. 1992;54(4):766\u20137.","journal-title":"Transplant"},{"issue":"2","key":"1828_CR22","doi-asserted-by":"publisher","first-page":"e1920294","DOI":"10.1001\/jamanetworkopen.2019.20294","volume":"3","author":"RJ Wong","year":"2020","unstructured":"Wong RJ, Singal AK. Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014\u20132019. JAMA Netw Open. 2020;3(2):e1920294.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1828_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3390\/ijerph15020177","volume":"15","author":"PH Wen","year":"2018","unstructured":"Wen PH, Lu CL, Strong C, Lin YJ, Chen YL, Li CY, et al. Demographic and urbanization disparities of liver transplantation in Taiwan. Int J Environ Res Public Health. 2018;15(2):117.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"1828_CR24","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/j.1600-6143.2011.03498.x","volume":"11","author":"AK Mathur","year":"2011","unstructured":"Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Sex-based disparities in liver transplant rates in the United States. Am J Transplant. 2011;11(7):1435\u201343.","journal-title":"Am J Transplant"},{"issue":"8","key":"1828_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.15537\/smj.2018.8.22467","volume":"39","author":"I Altraif","year":"2018","unstructured":"Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Med J. 2018;39(8):842\u20135.","journal-title":"Saudi Med J"},{"issue":"1","key":"1828_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jvh.13412","volume":"28","author":"H Razavi","year":"2021","unstructured":"Razavi H, Blach S, Razavi-Shearer D, Alqahtani SA, Polaris Observatory Collaborators. The case for simplifying and using absolute targets for viral hepatitis elimination goals. J Viral Hepat. 2021;28(1):12\u20139.","journal-title":"J Viral Hepat"},{"issue":"1","key":"1828_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.dld.2019.08.022","volume":"52","author":"AK Singal","year":"2020","unstructured":"Singal AK, Satapathy SK, Reau N, Wong R, Kuo YF. Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma. Dig Liver Dis. 2020;52(1):98\u2013101.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"1828_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jceh.2019.06.007","volume":"10","author":"F Shirazi","year":"2020","unstructured":"Shirazi F, Wang J, Wong RJ. Nonalcoholic steatohepatitis becomes the leading indication for liver transplant registrants among US Adults born between 1945 and 1965. J Clin Exp Hepatol. 2020;10(1):30\u20136.","journal-title":"J Clin Exp Hepatol"},{"key":"1828_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000001821","author":"J McPhail","year":"2020","unstructured":"McPhail J, Sims OT, Guo Y, Wooten D, Herndon JS, Massoud OI. Fibrosis improvement in patients with HCV treated with direct-acting antivirals. Eur J Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1097\/meg.0000000000001821.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"1828_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/jgh.14008","volume":"33","author":"A Facciorusso","year":"2018","unstructured":"Facciorusso A, Del Prete V, Turco A, Buccino RV, Nacchiero MC, Muscatiello N. Long-term liver stiffness assessment in hepatitis C virus patients undergoing antiviral therapy: Results from a 5-year cohort study. J Gastroenterol Hepatol. 2018;33(4):942\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"1828_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jgh3.12091","volume":"2","author":"J Romano","year":"2018","unstructured":"Romano J, Sims OT, Richman J, Guo Y, Matin T, Shoreibah M, et al. Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients. JGH Open. 2018;2(6):317\u201321.","journal-title":"JGH Open"},{"issue":"2","key":"1828_CR32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1053\/j.gastro.2018.04.008","volume":"155","author":"V Calvaruso","year":"2018","unstructured":"Calvaruso V, Cabibbo G, Cacciola I, Petta S, Madonia S, Bellia A, et al. Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents. Gastroenterology. 2018;155(2):411-421.e414.","journal-title":"Gastroenterology"},{"issue":"3","key":"1828_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/14728214.2016.1220533","volume":"21","author":"M Noureddin","year":"2016","unstructured":"Noureddin M, Zhang A, Loomba R. Promising therapies for treatment of nonalcoholic steatohepatitis. Expert Opin Emerg Drugs. 2016;21(3):343\u201357.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"1828_CR34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","volume":"17","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2019;17(4):748-755.e743.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1828_CR35","unstructured":"Global-Health-Obervatory-Data. Overweight and obesity: prevalence of overweight among adults. https:\/\/www.who.int\/gho\/ncd\/risk_factors\/overweight\/en\/. Accessed 18 Oct 2020."},{"key":"1828_CR36","unstructured":"Global-Health-Obervatory-Data. Prevalence of insufficient physical activity. https:\/\/www.who.int\/gho\/ncd\/risk_factors\/physical_activity_text\/en\/. Accessed 18 Oct 2020."},{"key":"1828_CR37","doi-asserted-by":"crossref","unstructured":"Obesity in Saudi Arabia in 2020: Prevalence, distribution, and its current association with various health conditions. Healthcare (Basel). 2021;9(3):311.","DOI":"10.3390\/healthcare9030311"},{"issue":"10","key":"1828_CR38","doi-asserted-by":"publisher","first-page":"e0239905","DOI":"10.1371\/journal.pone.0239905","volume":"15","author":"BA Mohamed","year":"2020","unstructured":"Mohamed BA, Mahfouz MS, Badr MF. Physical activity and its associated factors in females with type 2 diabetes in Riyadh, Saudi Arabia. PLoS ONE. 2020;15(10):e0239905.","journal-title":"PLoS ONE"},{"key":"1828_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10182-x","author":"FM Sanai","year":"2021","unstructured":"Sanai FM, Al Khathlan A, Al Fadhli A, Jazzar AS, Hashim AM, Mansour E, et al. Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait. Hepatol Int. 2021. https:\/\/doi.org\/10.1007\/s12072-021-10182-x.","journal-title":"Hepatol Int"},{"issue":"2","key":"1828_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S1499-3872(15)60346-0","volume":"14","author":"N Guler","year":"2015","unstructured":"Guler N, Yaprak O, Gunay Y, Dayangac M, Akyildiz M, Yuzer F, et al. Major complications of adult right lobe living liver donors. Hepatobiliary Pancreat Dis Int. 2015;14(2):150\u20136.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"1828_CR41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1440-1746.2011.06844.x","volume":"27","author":"EL de Graaf","year":"2012","unstructured":"de Graaf EL, Kench J, Dilworth P, Shackel NA, Strasser SI, Joseph D, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. J Gastroenterol Hepatol. 2012;27(3):540\u20136.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"1828_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/lt.23438","volume":"18","author":"ER Perito","year":"2012","unstructured":"Perito ER, Rhee S, Glidden D, Roberts JP, Rosenthal P. Impact of the donor body mass index on the survival of pediatric liver transplant recipients and post-transplant obesity. Liver Transplant. 2012;18(8):930\u20139.","journal-title":"Liver Transplant"},{"issue":"2","key":"1828_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12072-015-9664-7","volume":"10","author":"W Al-Hamoudi","year":"2016","unstructured":"Al-Hamoudi W, Abaalkhail F, Bendahmash A, Allam N, Hegab B, Elsheikh Y, et al. The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool. Hepatol Int. 2016;10(2):347\u201354.","journal-title":"Hepatol Int"},{"issue":"9","key":"1828_CR44","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.soard.2017.04.005","volume":"13","author":"A Alqahtani","year":"2017","unstructured":"Alqahtani A, Elahmedi M, Alswat K, Arafah M, Fagih M, Lee J. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. Surg Obes Relat Dis. 2017;13(9):1599\u2013609.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"1828_CR45","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","volume":"65","author":"R Pais","year":"2016","unstructured":"Pais R, Barritt AS, Calmus Y, Scatton O, Runge T, Lebray P, et al. NAFLD and liver transplantation: current burden and expected challenges. J Hepatol. 2016;65(6):1245\u201357.","journal-title":"J Hepatol"},{"issue":"4","key":"1828_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","volume":"24","author":"K Alswat","year":"2018","unstructured":"Alswat K, Aljumah AA, Sanai FM, Abaalkhail F, Alghamdi M, Al Hamoudi WK, et al. Nonalcoholic fatty liver disease burden\u2014Saudi Arabia and United Arab Emirates, 2017\u20132030. Saudi J Gastroenterol. 2018;24(4):211\u20139.","journal-title":"Saudi J Gastroenterol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01828-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-021-01828-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-021-01828-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:36:18Z","timestamp":1622547378000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-021-01828-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1828"],"URL":"https:\/\/doi.org\/10.1186\/s12876-021-01828-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"25 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On December 3, 2019, the Institutional Review Board of KFSHRC (Riyadh, SA) approved this study and waived the need for informed consent due to the retrospective and anonymous nature of the study (Approval Number: RAC 2,171,177). Authors declare that the present work was carried out in accordance with the WMA Declaration of Helsinki (adopted: 1964; last amended: 2013) and the WMA statement on measures for the prevention and fight against transplant-related crimes (adopted: October 2020). Authors also declare that no organs transplanted in the study subjects were obtained from prisoners.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"245"}}